sertraline has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blesl, C; Holl, A; Mörkl, S; Painold, A; Schmiedhofer, F; Tmava, A; Wurm, WE | 1 |
Cohen, BM; Forester, BP; Harper, DG; Jensen, JE; Jordan, B; Ravichandran, C; Renshaw, PF | 1 |
Couch, L; Fang, JL; Guo, L; Higuchi, M; Li, Y | 1 |
3 other study(ies) available for sertraline and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
[The power plants of the cell: Treatment of psychiatric symptoms in patients with mitochondriopathy].
Topics: Depressive Disorder; Female; Humans; Mitochondrial Diseases; Neuropsychological Tests; Panic Disorder; Personality; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2017 |
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression.
Topics: Aged; Antidepressive Agents; Case-Control Studies; Depressive Disorder, Major; Energy Metabolism; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondrial Diseases; Organophosphates; Phosphorus Isotopes; Sertraline | 2009 |
Mitochondrial dysfunction induced by sertraline, an antidepressant agent.
Topics: Adenosine Triphosphate; Animals; Antidepressive Agents; Bongkrekic Acid; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Energy Metabolism; Hepatocytes; L-Lactate Dehydrogenase; Male; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2012 |